A method for efficient expression of the restriction endonuclease MlUI

By transforming the MlUI gene into the ER2566 strain and purifying it using IPTG induction and Ni affinity chromatography, the problem of preparing high-purity and high-activity restriction endonucleases in existing technologies has been solved, achieving an efficient and low-cost preparation process.

CN116970588BActive Publication Date: 2026-11-17EAST CHINA UNIV OF SCI & TECH
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202311160684.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-09-08
Publication Date
2026-11-17
Estimated Expiration
2043-09-08

AI Technical Summary

Technical Problem

Existing methods for preparing restriction endonucleases are cumbersome and costly, making it difficult to obtain high-purity and high-activity restriction endonucleases like MlUI.

Method used

The MlUI gene was transformed into the ER2566 strain, and the preparation process was simplified and the production cost was reduced by inducing it with IPTG and purifying it with Ni affinity chromatography.

Benefits of technology

This study achieved efficient expression of the high-purity and high-activity restriction endonuclease MlUI, simplified the preparation process, reduced production costs, and provided a theoretical basis for large-scale industrial production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116970588B_ABST
    Figure CN116970588B_ABST
Patent Text Reader

Abstract

This invention belongs to the field of bioengineering technology, specifically relating to a method for efficiently expressing the restriction endonuclease MlUI. The specific steps include: transforming the MlUI gene into strain ER2566, culturing the ER2566 strain containing the MlUI gene to obtain an MlUI bacterial culture; inducing the MlUI bacterial culture with IPTG, purifying it, and obtaining the restriction endonuclease MlUI. This invention directly uses strain ER2566, eliminating the need for screening with methyltransferases, greatly simplifying the expression process. It simplifies the experimental method while ensuring enzyme activity, reduces production costs, and provides valuable theoretical and practical basis for large-scale industrial production of MlUI. Furthermore, the obtained restriction endonuclease MlUI exhibits high purity and high activity.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of bioengineering technology, specifically relating to a method for efficiently expressing the restriction endonuclease MlUI. Background Technology

[0002] Restriction endonucleases and methyltransferases are important tools in modern gene research. They are usually obtained from different microorganisms. Restriction endonucleases are responsible for degrading foreign DNA that enters prokaryotic cells, while methyltransferases methylate the cell's own DNA, thereby protecting the cell's DNA from degradation by intracellular restriction endonucleases. Because there are more than 200 varieties of restriction enzymes, originating from completely different sources and with no direct correlation between them, research and development cannot be generalized. Furthermore, restriction endonucleases specifically recognize and hydrolyze specific nucleotide sequences on double-stranded DNA, making them toxic proteins to host cells. Overexpression of these enzymes can lead to host cell death, preventing the production of the target protein. Therefore, the preparation of restriction endonucleases presents significant technical challenges.

[0003] The existing methods for producing restriction endonucleases mainly involve cloning restriction-modification genes into plasmids, relying on the high copy number of the plasmid to achieve high expression of the target protein, and using specific methyltransferases corresponding to the restriction endonucleases for preparation. This method has a complicated purification process and high production costs. How to reduce production costs and prepare high-purity restriction endonucleases has become an urgent technical problem to be solved. Summary of the Invention

[0004] The purpose of this invention is to address the shortcomings of existing technologies by proposing a method for efficiently expressing the restriction endonuclease MlUI, thereby obtaining the restriction endonuclease MlUI with high purity and high activity, and reducing production costs.

[0005] This invention provides a method for efficiently expressing the restriction endonuclease MlUI, comprising the following steps:

[0006] The MlUI gene was transformed into the ER2566 strain, and the ER2566 strain containing the MlUI gene was cultured to obtain the MlUI bacterial culture medium.

[0007] The MlUI bacterial culture was induced with IPTG and purified to obtain the restriction endonuclease MlUI.

[0008] Preferably, the method of transforming the MlUI gene into the ER2566 strain includes: recombining the MlUI gene with the basic plasmid to obtain a recombinant plasmid, and then transforming the ER2566 strain.

[0009] Preferably, the basic plasmid includes pET-28a.

[0010] Preferably, the concentration of IPTG is 0.1 mM to 1 mM.

[0011] Preferably, the induction conditions are 16℃~37℃ and 200~250rpm; the induction time is 4~18h.

[0012] Preferably, the purification is performed using a Ni affinity chromatography column.

[0013] Preferably, the purification step includes:

[0014] The culture medium of MlUI bacteria induced by IPTG was collected by centrifugation to collect the bacterial cells.

[0015] The bacterial cells were resuspended in Ni column binding buffer, lysed, and the supernatant was collected by centrifugation. The supernatant was purified by Ni affinity chromatography column, and eluted sequentially with equilibration buffer, wash buffer 1, wash buffer 2 and elution buffer. The eluents after elution with equilibration buffer, wash buffer 1, wash buffer 2 and elution buffer were collected separately, combined and dialyzed.

[0016] The dialysate obtained from the dialysis contains the restriction endonuclease MlUI;

[0017] The Ni column binding buffer has a pH of 7.4 and its composition includes: 20 mM Tris-HCl and 100 mM NaCl;

[0018] The equilibration buffer has a pH of 7.4 and its composition includes: 20 mM Tris-HCl and 100 mM NaCl;

[0019] The rinsing buffer 1 has a pH of 7.4 and its composition includes: 20 mM Tris-HCl, 100 mM NaCl, and 10 mM imidazole.

[0020] The rinsing buffer 2 has a pH of 7.4 and consists of: 20 mM Tris-HCl, 100 mM NaCl, and 30 mM imidazole.

[0021] The elution buffer has a pH of 7.4 and consists of 20 mM Tris-HCl, 100 mM NaCl, and 300 mM imidazole.

[0022] Beneficial effects:

[0023] ER2566 is a strain obtained by replacing a portion of the BL21 genome sequence with homologous sequences from K-12. After introducing 6% of the K-12 genome sequence, ER2566 exhibits a different phenotype from BL21, showing tolerance to DNA damage caused by non-specific nucleases. Furthermore, the CDS sequence of ER2566 contains methyltransferases and methylases (e.g., DNA adenine methylase, which methylates adenine in bacterial DNA molecules to form 6'-methyladenine, protecting the cell's own DNA from restriction endonuclease damage). Directly transforming the MlUI gene into ER2566 creates an engineered bacterium containing the MlUI gene. The methyltransferases in ER2566 itself protect the host DNA from cleavage by restriction endonucleases within the host cell, eliminating the need for additional methyltransferase selection and greatly simplifying the expression process. This invention simplifies the experimental method while maintaining enzyme activity, reduces production costs, and provides valuable theoretical and practical basis for large-scale industrial production of MlUI.

[0024] Furthermore, this invention uses pET-28a as the base vector. Since pET-28a has a 6X His purification tag coding sequence, the recombinant protein expressed in the end contains a 6X His purification tag, which greatly simplifies the purification of the target protein. Attached Figure Description

[0025] To more clearly illustrate the technical solutions in the embodiments of the present invention or the prior art, the accompanying drawings used in the embodiments will be briefly described below.

[0026] Figure 1 The results of SDS-PAGE electrophoresis of MlUI after purification by Ni column;

[0027] Figure 2 Here is an agarose gel electrophoresis image of the MlUI digested enzyme;

[0028] Figure 3 The SDS-PAGE electrophoresis results are for M1UI after expression with BL21(DE3). Detailed Implementation

[0029] This invention provides a method for efficiently expressing the restriction endonuclease MlUI, comprising the following steps:

[0030] The MlUI gene was transformed into the ER2566 strain, and the ER2566 strain containing the MlUI gene was cultured to obtain the MlUI bacterial culture medium.

[0031] The MlUI bacterial culture was induced with IPTG and purified to obtain the restriction endonuclease MlUI.

[0032] This invention transforms the MlUI gene into the ER2566 strain to obtain an ER2566 strain containing the MlUI gene. Preferably, the method of transforming the MlUI gene into the ER2566 strain includes: recombining the MlUI gene with a basic plasmid to obtain a recombinant plasmid, which is then transformed into the ER2566 strain. The ER2566 strain used in this invention is a strain obtained by replacing a portion of the BL21 genome sequence with a homologous sequence of K-12. After introducing 6% of the K-12 genome sequence, the phenotype of the ER2566 strain differs from BL21, exhibiting tolerance to DNA damage caused by non-specific nucleases. Its own methyltransferase can protect the host DNA from cleavage by some restriction endonucleases within the host cell, eliminating the need for selection using methyltransferases and greatly simplifying the expression process. The ER2566 strain described in this invention is preferably purchased from Shanghai Weidi Biotechnology Co., Ltd.

[0033] In this invention, the base plasmid is preferably pET-28a. This invention uses pET-28a as the base plasmid to construct recombinant plasmids. Because the vector pET-28a has a 6X His purification tag coding sequence, the final expressed recombinant protein contains a 6X His purification tag, further simplifying the purification process of the target protein.

[0034] After obtaining the ER2566 strain containing the MlUI gene, the present invention cultured the ER2566 strain containing the MlUI gene to obtain the MlUI bacterial culture medium.

[0035] In this invention, the culture temperature is preferably 30℃~37℃, more preferably 37℃; the culture time is preferably 3~15h, more preferably 5~10h, and more preferably 8h. Preferably, during the culture process, an antibiotic is added to the culture medium according to the resistance gene of the basal plasmid. When the basal plasmid is pET-28a, the antibiotic corresponding to the resistance gene is kanamycin; the culture medium for culturing the ER2566 strain containing the MlUI gene is preferably LB medium containing 50μg / mL kanamycin.

[0036] After obtaining the MlUI bacterial culture medium, the present invention uses IPTG to induce the MlUI bacterial culture medium to obtain an induced MlUI bacterial culture medium. In the present invention, during the induction, the inoculum amount of MlUI bacteria is preferably 2% to 5% of the culture medium volume, the concentration of IPTG is preferably 0.1 mM to 1 mM, more preferably 0.5 mM; the induction temperature is preferably 16℃ to 37℃, more preferably 20℃; the induction speed is preferably 200 to 250 rpm, more preferably 220 rpm; the induction time is preferably 4 to 18 h, more preferably 12 to 16 h, more preferably 15 h.

[0037] In this invention, the purification preferably uses a Ni affinity chromatography column; the purification steps preferably include:

[0038] The culture medium of MlUI bacteria induced by IPTG was collected by centrifugation to collect the bacterial cells.

[0039] The bacterial cells were resuspended in Ni column-binding buffer and then lysed.

[0040] In this invention, the centrifugation conditions are preferably 4°C, 4000 rpm to 12000 rpm; the centrifugation time is preferably 10 min. The crushing is preferably performed using a high-pressure homogenizer; the crushing conditions are preferably 820 bar to 860 bar; the crushing time is preferably 3 min.

[0041] After the bacterial cells are lysed, the lysed bacterial cells are centrifuged, and the supernatant is passed through a Ni affinity chromatography purification column. The cells are eluted sequentially with equilibration buffer, wash buffer 1 and 2 and elution buffer. The eluents eluted with equilibration buffer, wash buffer and elution buffer are collected separately, combined and dialyzed.

[0042] The dialysate obtained from the dialysis contains the restriction endonuclease MlUI.

[0043] In this invention, the volume ratio of the equilibration buffer, rinsing buffer 1, rinsing buffer 2 and elution buffer to the bacterial supernatant during elution is preferably 1:10.

[0044] In this invention, the preferred centrifugation conditions for the broken bacterial cells are 12,000 rpm, and the preferred centrifugation time is 30 min.

[0045] In this invention, the dialysis is preferably performed overnight in a dialysis bag with a molecular weight cutoff of 7 kDa, and the components of the dialysis solution used in the dialysis preferably include 20 mM Tris and 200 mM NaCl.

[0046] In this invention, the pH of the Ni column binding buffer is preferably 7.4, and its composition preferably includes: 20mM Tris-HCl and 100mM NaCl.

[0047] In this invention, the pH of the equilibration buffer is preferably 7.4, and its composition preferably includes: 20mM Tris-HCl and 100mM NaCl.

[0048] In this invention, the pH of the rinsing buffer 1 is preferably 7.4, and its composition preferably includes: 20mM Tris-HCl, 100mM NaCl, and 10mM imidazole.

[0049] In this invention, the pH of the rinsing buffer 2 is preferably 7.4, and its composition preferably includes: 20mM Tris-HCl, 100mM NaCl, and 30mM imidazole.

[0050] In this invention, the pH of the elution buffer is preferably 7.4, and its composition preferably includes: 20mM Tris-HCl, 100mM NaCl, and 300mM imidazole.

[0051] To further illustrate the present invention, the method for efficiently expressing the restriction endonuclease MlUI provided by the present invention will be described in detail below with reference to the accompanying drawings and embodiments, but these should not be construed as limiting the scope of protection of the present invention.

[0052] Example 1

[0053] 1.1 Construction of plasmid vectors

[0054] The MlUI gene (GenBank: AEN71951.1) was inserted into the 3' end of the T7 promoter of the PET-28a plasmid to obtain the MlUI plasmid. The MlUI plasmid was centrifuged, dissolved in 100 mL of ultrapure water, and 3 mL was added to E. coli DH5α under sterile conditions. The mixture was incubated on ice for 20 min. It was then heat-shocked in a 42℃ water bath for 90 s, followed by an ice bath for 2 min. 800 mL of LB solution was added to E. coli DH5α, and the mixture was incubated with shaking at 210 rpm and 37℃ for 45 min. After incubation, the mixture was centrifuged at 12000 rpm for 2 min, and the supernatant was discarded under sterile conditions. The bacterial resuspended in 150 mL of water and spread onto Kansas. + Plasmids were extracted and sequenced after culturing on LB solid medium (50 μg / mL) at 37°C and 220 rpm for 12 h with shaking. Plasmids showing a nucleotide sequence identical to the MlUI gene were identified as positive MlUI plasmids and stored in E. coli DH5α.

[0055] 1.2 Preparation of competent cells

[0056] 500 μL of ER2566 strain was inoculated into 50 mL of LB liquid medium and cultured at 37 °C with shaking at 220 rpm for 4 h. The OD of the bacterial culture was then calculated. 600 When the pH value is between 0.4 and 0.5, transfer the bacterial culture to a 50 mL centrifuge tube, incubate on ice for 20 min, centrifuge at 4000 rpm for 10 min at 4°C, and discard the supernatant. Add 10 mL of pre-chilled 0.1 M CaCl2 to the precipitate, resuspend the precipitate, and then centrifuge again at 4000 rpm for 10 min at 4°C, discarding the supernatant. Repeat the above resuspension-centrifugation-supernatant discarding process twice. Finally, add 3 mL of pre-chilled 0.1 M CaCl2 to the precipitate, resuspend the cells again to obtain competent cells. Aliquot the competent cells using a pipette, adding 100 μL of cell resuspension to each 1.5 mL EP tube, followed by 100 μL of 50% glycerol, and store at -80°C.

[0057] 1.3 Transformation

[0058] Take the positive MlUI plasmid obtained in step 1.1, thaw it at room temperature, add 10 μL of the MlUI plasmid solution to the competent cells obtained in step 1.2, gently vortex to mix, and incubate on ice for 25 min. Then place the bacterial culture in a 42℃ water bath for heat shock for 45 s, followed by incubation on ice for 2 min. Next, add 2 mL of LB liquid medium to the bacterial culture and culture at 220 rpm and 37℃ with shaking for 60 min. Spread 50 μL of the bacterial culture onto LB solid medium with a Kan+ concentration of 50 μg / mL and incubate overnight.

[0059] 1.4 Sequencing and Preservation

[0060] Plasmids were extracted from single colonies cultured overnight in step 1.3 and then sequenced. The sequencing results revealed a nucleotide sequence identical to the MlUI gene, yielding a recombinant bacterium, namely the ER2566 strain containing the MlUI gene.

[0061] Recombinant bacteria were inoculated into Kan + The culture was incubated in LB liquid broth with a concentration of 50 μg / mL at 37°C and shaken at 250 rpm for 16 h. 700 μL of the bacterial culture was then injected into a cryovial, and 50% glycerol was added at a volume ratio of 1:1 to obtain MlUI glycerol bacteria.

[0062] 1.5 Culture of Recombinant Bacteria

[0063] Take 1 mL of glycerol bacteria and add 50 mL of Kan. + The culture was incubated in LB liquid medium at 50 μg / mL at 37°C and 220 rpm for 8 hours with shaking. Then, 50 mL of the bacterial culture was added to 450 mL of Kansas liquid.+ In LB liquid culture medium with a concentration of 50 μg / mL, the culture was incubated at 37°C and 220 rpm for 3 hours with shaking, until the OD of the bacterial culture was reached. 600 The value is 0.6 to 0.8, and the pre-induction bacterial solution is obtained.

[0064] Add IPTG solution to the pre-induction bacterial culture to a final concentration of 1 mM, incubate on ice for 10 min, then incubate at 20°C with shaking at 200 rpm to 250 rpm for 12 to 18 h to obtain the induced bacterial culture (approximately 500 mL).

[0065] 1.6 Purification

[0066] (1) Centrifuge the induced bacterial culture from step 1.5 at 4°C and 4000 rpm for 10 min, and collect the cell pellet. Resuspend the cell pellet in 50 mL of a solution of 20 mM Tris-HCl and 100 mM NaCl (pH 7.4). Add the resuspended bacterial culture to a pre-cooled autoclave at 4°C and cycle at 820 bar for 3 min to break the bacteria. After the autoclave breaks the bacteria, recover the bacterial culture and centrifuge at 4°C and 12000 rpm for 30 min, and collect the supernatant.

[0067] (2) Take 50 mL of the collected supernatant and add it to a Ni-NTA column that has been rinsed with 20 mM Tris buffer at pH 7.4. Place the column on a shaker and shake for 3 h at 4 °C and 200 rpm. Collect the flow-through. After binding, wash the column sequentially with 50 mL of equilibration buffer, wash buffer 1, wash buffer 2, and elution buffer. The information for each buffer is shown in Table 1 below. Collect the eluent after each wash.

[0068] Table 1 Composition of each buffer solution

[0069]

[0070] The collected eluents were combined and transferred to a dialysis bag with a molecular weight cutoff of 7 kDa. Dialysis was performed overnight in 3 L of dialysis buffer (20 mM Tris, 200 mM NaCl) at pH 7.4. The dialyzed protein was then transferred to a 50 mL centrifuge tube and centrifuged at 12000 rpm for 30 min. The supernatant was collected to obtain the purified restriction endonuclease MIUI. The dialyzed protein was concentrated to an A280 of approximately 0.56. The protein was added to a mixture of 2 mM DTT and 0.2 mM EDTA, followed by the addition of 50% glycerol. The mixture was sterilized by 0.2 μm filtration and stored at -20°C.

[0071] Test Example 1

[0072] The following bacterial cultures were collected in Example 1: pre-induction bacterial culture (referred to as pre-induction), post-induction bacterial culture (referred to as post-induction), supernatant collected in step (1) of step 1.6 (referred to as supernatant), flow-through liquid after centrifugation in step (2) of step 1.6 (referred to as flow-through), elution buffer after rinsing (referred to as 0 mM), elution buffer 1 after rinsing (referred to as 10 mM), elution buffer 2 after rinsing (referred to as 30 mM), elution buffer after rinsing (referred to as 300 mM), combined elution buffer before dialysis (referred to as elution), and dialysis buffer after dialysis to remove precipitate (referred to as post-dialysis). These were used as experimental samples for SDS-PAGE experiments. The sample loading volume was 5 μL. The results are as follows: Figure 1 As shown.

[0073] according to Figure 1 As can be seen, a 30.2 kDa protein band appeared after elution with elution buffer, confirming that the target protein was in the eluent after elution with elution buffer. Nanodrop 2000 testing showed that the A280 value of MlUI before dialysis was 0.64, and the A280 value of MlUI after dialysis was 0.56, with a volume of 50 mL. The protein mass of MlUI was calculated using the following formula: m = A280 × M × V ÷ Extinction coefficient

[0074] Where m represents mass, A280 represents the A280 value after dialysis, M represents the relative molecular mass of MlUI, and V represents the volume after dialysis; the extinction coefficient is 38.39; where the value of A280 ÷ extinction coefficient represents the molar concentration of MlUI.

[0075] The yield of MlUI protein in 500 mL of induced bacterial culture was 22.02 mg. This demonstrates that the method of the present invention can prepare high-purity restriction endonuclease MlUI.

[0076] Test Example 2

[0077] pET-28a plasmid containing the MlUI restriction site was prepared. The restriction reaction system was then prepared according to Table 2, and the restriction conditions were 37℃ for 15 min. Agarose gel electrophoresis was performed on the digested system, with a loading volume of 3 μL. The results are shown below. Figure 2 As shown.

[0078] Table 2 Enzyme digestion system for swimming lanes

[0079]

[0080] in, Figure 2 The fragment size is 5.2kb / 1.8kb. (By...) Figure 2It can be seen that the restriction endonuclease MlUI prepared in Example 1 has the same digestion results as the restriction endonuclease MlUI in the kit provided by Thermo, indicating that the method of the present invention can prepare highly active restriction endonuclease MlUI.

[0081] Test Example 3

[0082] 1. The restriction endonuclease MlUI was expressed in accordance with the method of Example 1. The induction methods of Comparative Examples 1 to 12 were the same as those in Example 1. The difference was that the ER2566 strain was replaced with the BL21(DE3) strain, the concentration of IPTG added during induction culture was different, and the induction culture temperature and time were different, as shown in Table 3.

[0083] Table 3. Temperature, time, and IPTG concentration of induction culture for Comparative Examples 1–12

[0084]

[0085] 2. The fermentation broths obtained from Comparative Examples 1 to 12 were used as experimental samples for SDS-PAGE experiments. The sample loading volume was 5 μL for each experiment. The results are as follows: Figure 3 As shown.

[0086] Depend on Figure 3 It can be seen that no overexpression bands were found in the fermentation broths of Comparative Examples 1 to 12 after gel running, indicating that the BL21(DE3) strain cannot achieve high expression of the restriction endonuclease MlUI.

[0087] As can be seen from the above embodiments, the present invention uses the ER2566 strain to express the restriction endonuclease MlUI, which can achieve high expression of the restriction endonuclease MlUI and obtain high-purity MlUI.

[0088] Although the above embodiments have provided a detailed description of the present invention, they are only some embodiments of the present invention, and not all embodiments. People can obtain other embodiments based on these embodiments without creative effort, and these embodiments all fall within the protection scope of the present invention.

Claims

1. A method for efficient expression of restriction enzyme Mlul, characterized by, The steps of the method are as follows: The MlUI gene was transformed into the ER2566 strain to obtain the ER2566 engineered strain; The ER2566 engineered bacteria were cultured to obtain MlUI bacterial culture medium; The MlUI bacterial culture was induced by IPTG, purified, and the restriction endonuclease MlUI was obtained. The process of transforming the MlUI gene into the ER2566 strain includes: recombining the MlUI gene with the basic plasmid, and transforming the resulting recombinant plasmid into the ER2566 strain. The basic plasmid includes pET-28a; The methyltransferase of the ER2566 strain itself can protect the host DNA from cleavage by MlUI, eliminating the need for additional methyltransferase selection.

2. The method of claim 1, wherein, The concentration of IPTG in the culture medium is 0.1 mM to 1 mM.

3. The method of claim 1, wherein, The induction conditions are 16℃~37℃, 200~250rpm; the induction time is 4~18h.

4. The method according to any one of claims 1 to 3, characterized in that, The purification was performed using Ni affinity chromatography.

5. The method of claim 4, wherein, The purification process includes the following steps: Centrifuge the IPTG-induced MlUI bacterial culture medium to collect the bacterial cells; The bacterial cells were resuspended in Ni column binding buffer, lysed, and the supernatant was collected by centrifugation and purified by Ni affinity chromatography column. Elution was performed sequentially with equilibration buffer, rinsing buffer 1, rinsing buffer 2 and elution buffer. The eluents eluted with equilibration buffer, rinsing buffer and elution buffer were collected separately, combined and dialyzed. The Ni column binding buffer has a pH of 7.4 and consists of 20 mM Tris-HCl and 100 mM NaCl. The equilibration buffer has a pH of 7.4 and consists of 20 mM Tris-HCl and 100 mM NaCl. The rinsing buffer 1 has a pH of 7.4 and consists of: 20 mM Tris-HCl, 100 mM NaCl, and 10 mM imidazole. The rinsing buffer 2 has a pH of 7.4 and consists of: 20 mM Tris-HCl, 100 mM NaCl, and 30 mM imidazole. The elution buffer has a pH of 7.4 and consists of 20 mM Tris-HCl, 100 mM NaCl, and 300 mM imidazole.

Citation Information

Patent Citations

  • Method for protecting efficient recombinant expression of restriction enzymes by virtue of methylase

    CN106480076A